Phosphorylation and intramolecular stabilization of the ligand binding domain in the nuclear receptor steroidogenic factor 1

Molecular and Cellular Biology

Volumn 22, Issue 20, 2002, Pages 7193-7203

  Desclozeaux, Marion ^a   Krylova, Irina N ^a   Horn, Florence ^a   Fletterick, Robert J ^a   Ingraham, Holly A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; SERINE; STEROIDOGENIC FACTOR 1; THYROID HORMONE;

ANIMAL CELL; ARTICLE; ASSAY; CHIMERA; CONTROLLED STUDY; IMMUNOBLOTTING; LIGAND BINDING; MOUSE; NONHUMAN; PHOSPHORYLATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SECONDARY STRUCTURE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; BINDING SITES; DNA-BINDING PROTEINS; FUSHI TARAZU TRANSCRIPTION FACTORS; HELIX-LOOP-HELIX MOTIFS; HOMEODOMAIN PROTEINS; HUMANS; LIGANDS; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, THYROID HORMONE; RECOMBINANT FUSION PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; THYROID HORMONE RECEPTORS BETA; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0036787839     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.20.7193-7203.2002     Document Type: Article

References (58)

1. Allan, G. F., X. H. Leng, S. Y. Tsai, N. L. Weigel, D. P. Edwards, M. J. Tsai, and B. W. Omalley. 1992. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. J. Biol. Chem. 267:19513-19520.
2. Benecke, A., P. Chambon, and H. Gronemeyer. 2000. Synergy between estrogen receptor alpha activation functions AF1 and AF2 mediated by transcription intermediary factor TIF2. EMBO Rep. 1:151-157.
3. Billas, I. M., L. Moulinier, N. Rochel, and D. Moras. 2001. Crystal structure of the ligand-binding domain of the ultraspiracle protein USP, the ortholog of retinoid X receptors in insects. J. Biol. Chem. 276:7465-7474.
4. Bourguet, W., V. Vivat, J. M. Wurtz, P. Chambon, H. Gronemeyer, and D. Moras. 2000. Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol. Cell 5:289-298.
5. Christenson, L. K., J. M. McAllister, K. O. Martin, N. B. Javitt, T. F. Osborne, and J. F. Strauss III. 1998. Oxysterol regulation of steroidogenic acute regulatory protein gene expression. Structural specificity and transcriptional and posttranscriptional actions. J. Biol. Chem. 273:30729-30735.
6. Crawford, P. A., J. A. Polish, G. Ganpule, and Y. Sadovsky. 1997. The activation function-2 hexamer of steroidogenic factor-1 is required, but not sufficient for potentiation by SRC-1. Mol. Endocrinol. 11:1626-1635.
7. Egea, P. F., A. Mitschler, N. Rochel, M. Ruff, P. Chambon, and D. Moras. 2000. Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis-retinoic acid. EMBO J. 19:2592-2601.
8. Glass, C. K., and M. G. Rosenfeld. 2000. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14:121-141.
9. Greenfield, N., V. Vijayanathan, T. J. Thomas, M. A. Gallo, and T. Thomas. 2001. Increase in the stability and helical content of estrogen receptor alpha in the presence of the estrogen response element: analysis by circular dichroism spectroscopy. Biochemistry 40:6646-6652.
10. Hammer, G. D., and H. A. Ingraham. 1999. Steroidogenic factor-1: its role in endocrine organ development and differentiation. Front. Neuroendocrinol. 20:199-223.
11. Hammer, G. D., I. Krylova, Y. X. Zhang, B. D. Darimont, K. Simpson, N. L. Weigel, and H. A. Ingraham 1999. Phosphorylation of the nuclear receptor SF-1 modulates cofactor recruitment: integration of hormone signaling in reproduction and stress. Mol. Cell 3:521-526.
12. Horn, F., G. Vriend, and F. E. Cohen. 2001. Collecting and harvesting biological data: the GPCRDB and NucleaRDB information systems. Nucleic Acids Res. 29:346-349.
13. Hu, M. C., N. C. Hsu, C. I. Pai, C. K. Wang, and B. Chung. 2001. Functions of the upstream and proximal steroidogenic factor 1 (SF-1)-binding sites in the CYP11A1 promoter in basal transcription and hormonal response. Mol. Endocrinol. 15:812-818.
14. Iniguez-Lluhi, J. A., and D. Pearce. 2000. A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy. Mol. Cell. Biol. 20:6040-6050.
15. Ito, M., Y. Park, J. Week, K. E. Mayo, and J. L. Jameson. 2000. Synergistic activation of the inhibin alpha-promoter by steroidogenic factor-1 and cyclic adenosine 3′, 5′-monophosphate. Mol. Endocrinol. 14:66-81.
16. Jacob, A. L., and J. Lund. 1998. Mutations in the activation function-2 core domain of steroidogenic factor-1 dominantly suppresses PKA-dependent transactivation of the bovine CYP17 gene. J. Biol. Chem. 273:13391-13394.
17. Karplus, K., C. Barrett, and R. Hughey. 1998. Hidden Markov models for detecting remote protein homologies. Bioinformatics 14:846-856.
18. Kumar, R., and E. B. Thompson. 1999. The structure of the nuclear hormone receptors. Steroids 64:310-319.
19. Lanz, R. B., N. J. McKenna, S. A. Onate, U. Albrecht, J. Wong, S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 1999. A steroid receptor coactivator, SRA, functions as an RNA and is present in an SRC-1 complex. Cell 97:17-27.
20. Le, T., and B. P. Schimmer. 2001. The regulation of mapks in yl mouse adrenocortical tumor cells. Endocrinology 142:4282-4287.
21. Leng, X. H., S. Y. Tsai, B. W. Omalley, and M. J. Tsai. 1993. Ligand-dependent conformational changes in thyroid hormone and retinoic acid receptors are potentially enhanced by heterodimerization with retinoic X receptor. J. Steroid Biol. Mol. Biol. 46:643-661.
22. Li, L. A., E. F. Chiang, J. C. Chen, N. C. Hsu, Y. J. Chen, and B. C. Chung. 1999. Function of steroidogenic factor 1 domains in nuclear localization, transactivation, and interaction with transcription factor TFIIB and c-Jun. Mol. Endocrinol. 13:1588-1598.
23. Liebmann, C. 2001. Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity. Cell Signal. 13:777-785.
24. Liu, Z., and E. R. Simpson. 1997. Steroidogenic factor 1 (SF-1) and SP1 are required for regulation of bovine CYP11A gene expression in bovine luteal cells and adrenal Y1 cells. Mol. Endocrinol. 11:127-137.
25. Lopez, G. N., C. W. Turek, F. Schaufele, M. R. Stalleup, and P. J. Kushner. 2001. Growth factors signal to steroid receptors through mitogen-activated protein kinase regulation of p160 coactivator activity. J. Biol. Chem. 276: 22177-22182.
26. Lund, J., M. Bakke, G. Mellgren, K. Morohashi, and S. O. Doskeland. 1997. Transcriptional regulation of the bovine CYP17 gene by cAMP. Steroids 62:43-45.
27. Maglich, J. M., A. Sluder, X. Guan, Y. Shi, D. D. McKee, K. Carrick, K. Kamdar, T. M. Willson, and J. T. Moore. 2001. Comparison of complete nuclear receptor sets from the human, Caenorhabditis elegans and Drosophila genomes. Genome Biol. 2(8):research 0029:1-0029:7.
28. Mascrez, B., M. Mark, W. Krezel, V. Dupe, M. LeMeur, N. B. Ghyselinck, and P. Chambon. 2001. Differential contributions of AF-1 and AF-2 activities to the developmental functions of RXR alpha. Development 128:2049-2062.
29. Milhon, J., S. Lee, K. Kohli, D. Chen, H. Hong, and M. R. Stallcup. 1997. Identification of amino acids in the tau 2-region of the mouse glucocorticoid receptor that contribute to hormone binding and transcriptional activation. Mol. Endocrinol. 11:1795-1805.
30. Norris, J. D., D. Fan, S.A. Kerner, and D. P. McDonnell. 1997. Identification of a third autonomous activation domain within the human estrogen receptor. Mol. Endocrinol. 11:747-754.
31. Ou, Q., J. F. Mouillet, X. Yan, C. Dorn, P. A. Crawford, and Y. Sadovsky. 2001. The DEAD box protein DP103 is a regulator of steroidogenic factor-1. Mol. Endocrinol. 15:69-79.
32. Ouali, M., and R. D. King. 2000. Cascaded multiple classifiers for secondary structure prediction. Protein Sci. 9:1162-1176.
33. Parker, K. L., and B. P. Schimmer. 1997. Steroidogenic factor 1: a key determinant of endocrine development and function. Endocr. Rev. 18:361-377.
34. Pissios, P., I. Tzameli, P. Kushner, and D. D. Moore. 2000. Dynamic stabilization of nuclear receptor ligand binding domains by hormone or corepressor binding. Mol. Cell 6:245-253.
35. Pollastri, G., P. Baldi, P. Fariselli, and R. Casadio. 2001. Improved prediction of the number of residue contacts in proteins by recurrent neural networks. Bioinformatics 17(Suppl. 1):S234-S242.
36. Rachez, C., and L. P. Freedman. 2001. Mediator complexes and transcription. Curr. Opin. Cell Biol. 13:274-280.
37. Radhakrishnan, I., G. C. Perez-Alvarado, D. Parker, H. J. Dyson, M. R. Montminy, and P. E. Wright. 1997. Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator: coactivator interactions. Cell 91:741-752.
38. Reiss, N., L. N. Llevi, S. Shacham, D. Harris, R. Seger, and Z. Naor. 1997. Mechanism of mitogen-activated protein kinase activation by gonadotropin-releasing hormone in the pituitary of alphaT3-1 cell line: differential roles of calcium and protein kinase C. Endocrinology. 138:1673-82.
39. Renaud, J. P., and D. Moras. 2000. Structural studies on nuclear receptors. Cell. Mol. Life Sci. 57:1748-1769.
40. Renaud, J. P., N. Rochel, M. Ruff, V. Vivat, P. Chambon, H. Gronemeyer, and D. Moras. 1995. Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature 378:681-689.
41. Richards, J. S. 2001. New signaling pathways for hormones and cyclic adenosine 3′,5′-monophosphate action in endocrine cells. Mol. Endocrinol. 15: 209-218.
42. Robinson-Rechavi, M., A. Carpentier, M. Duffraisse, and V. Laudet. 2001. How many nuclear hormone receptors are there in the human genome? Trends Genet. 17:554-556.
43. Rost, B. 1996. PHD: predicting one-dimensional protein structure by profile-based neural networks. Methods Enzymol. 266:525-539.
44. Rost, B., and C. Sander. 1994. Combining evolutionary information and neural networks to predict protein secondary structure. Proteins 19:55-72.
45. Samuels, M. L., M. J. Weber, J. M. Bishop, and M. McMahon. 1993. Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase. Mol. Cell. Biol. 13:6241-6252.
46. Shao, D. L., and M. A. Lazar. 1999. Modulating nuclear receptor function: may the phos be with you. J. Clin. Investig. 103:1617-1618.
47. Stehlin, C., J. M. Wurtz, A. Steinmetz, E. Greiner, R. Schule, D. Moras, and J. P. Renaud. 2001. X-ray structure of the orphan nuclear receptor RORbeta ligand-binding domain in the active conformation. EMBO J. 20:5822-5831.
48. Toney, J. H., L. Wu, A. E. Summerfield, G. Sanyal, B. M. Forman, J. B. Zhu, and H. H. Samuels. 1993. Conformational changes in chicken thyroid hormone receptor-alpha-1 induced by binding to ligand or to DNA. Biochemistry 32:2-6.
49. Tremblay, A., G. B. Tremblay, F. Labrie, and V. Giguere. 1999. Ligand-independent recruitment of SRC-1 to estrogen receptor beta through phosphorylation of activation function AF-1. Mol. Cell 3:513-519.
50. Vriend, G. 1990. WHAT IF: a molecular modeling and drug design program. J. Mol. Graph.8:52-56.
51. Vriend, G., and V. Eijsink. 1993. Prediction and analysis of structure, stability and unfolding of thermolysin-like proteases. J. Comput. Aided Mol. Des. 7:367-396.
52. Wagner, R. L., J. W. Apriletti, M. E. McGrath, B. L. West, J. D. Baxter, and R. J. Fletteriek. 1995. A structural role for hormone in the thyroid hormone receptor. Nature. 378:690-697.
53. Wagner, R. L., B. R. Huber, A. K. Shiau, A. Kelly, S. T. Cunha Lima, T. S. Scanlan, J. W. Apriletti, J. D. Baxter, B. L. West, and R. J. Fletterick. 2001. Hormone selectivity in thyroid hormone receptors. Mol. Endocrinol. 15:398-410.
54. Webb, P., C. M. Anderson, C. Valentine, P. Nguyen, A. Marimuthu, B. L. West, J. D. Baxter, and P. J. Kushner. 2000. The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs). Mol. Endocrinol. 14:1976-1985.
55. Webb, P., P. Nguyen, J. Shinsako, C. Anderson, W. Feng, M. P. Nguyen, D. Chen, S. M. Huang, S. Subramanian, E. McKinerney, B. S. Katzenellenbogen, M. R. Stalleup, and P. J. Kushner. 1998. Estrogen receptor activation function I works by binding p160 coactivator proteins. Mol. Endocrinol. 12:1605-1618.
56. Weigel, N. L. 1996. Steroid hormone receptors and their regulation by phosphorylation. Biochem J. 319:657-667.
57. Wu, Y., P. Delerive, W. W. Chin, and T. P. Burris. 2002. Requirement of helix 1 and the AF-2 domain of the thyroid hormone receptor for coactivation by PGC-1. J. Biol. Chem. 277:8898-8905.
58. Yang, L., J. Guerrero, H. Hong, D. B. DeFranco, and M. R. Stalleup. 2000. Interaction of the tau2 transcriptional activation domain of glucocorticoid receptor with a novel steroid receptor coactivator, Hic-5, which localizes to both focal adhesions and the nuclear matrix. Mol. Biol. Cell 11:2007-2018.